RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      연1회 정주용 졸레드론산의 순응도 분석 = Analysis of the Adherence in Once Yearly Intravenous Zoledronic Acid

      한글로보기

      https://www.riss.kr/link?id=A101599063

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Objectives: We investigated drug adherence of once yearly intravenous bisphosphonate in patients with osteoporosis or osteoporotic fractures, and factors that influence their adherence.

      Materials and Methods: Patients treated with once yearly intravenous bisphosphonate were asked about drug information and drug adherence using questionnaires. Factors related drug adherence were analyzed between non adherence group and adherence group.

      Results: 65 patients (49.6%) were adherence group, 66 patients (50.3%) were included in non-adherence group. In group 1, were administered mainly due to ‘after physicians suggestion’ in 22 cases (36.1%) and ‘for ease of administration’ in 17 cases (27.9%). In group 2, the patients were not readministered mainly due to economic reasons in 21 cases (42%), unconcerning to osteoporosis in 14 cases (28%).

      Conclusions: This study shows ‘doctor's suggestion’ and ‘ease of administration’ could enhance drug adherence.
      번역하기

      Objectives: We investigated drug adherence of once yearly intravenous bisphosphonate in patients with osteoporosis or osteoporotic fractures, and factors that influence their adherence. Materials and Methods: Patients treated with once yearly intrave...

      Objectives: We investigated drug adherence of once yearly intravenous bisphosphonate in patients with osteoporosis or osteoporotic fractures, and factors that influence their adherence.

      Materials and Methods: Patients treated with once yearly intravenous bisphosphonate were asked about drug information and drug adherence using questionnaires. Factors related drug adherence were analyzed between non adherence group and adherence group.

      Results: 65 patients (49.6%) were adherence group, 66 patients (50.3%) were included in non-adherence group. In group 1, were administered mainly due to ‘after physicians suggestion’ in 22 cases (36.1%) and ‘for ease of administration’ in 17 cases (27.9%). In group 2, the patients were not readministered mainly due to economic reasons in 21 cases (42%), unconcerning to osteoporosis in 14 cases (28%).

      Conclusions: This study shows ‘doctor's suggestion’ and ‘ease of administration’ could enhance drug adherence.

      더보기

      참고문헌 (Reference)

      1 Hamilton B, "Tolerability and compliance with risedronate in clinical practice" 14 : 259-262, 2003

      2 Rees MCP, "The need to improve compliance to HRT" 104 : 1-3, 1997

      3 Park HM, "The Use of Osteoporosis Medications in Korea in 2008" 16 : 87-93, 2009

      4 Chung JY, "Practice Patterns on Osteoporosis Screening and Treatment at Orthopaedic Surgery Outpatient Unit and the Issue on Different Osteoporosis Treatment Guidelines in Korea" 15 : 49-57, 2008

      5 Imaz I, "Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis" 21 : 1943-1951, 2010

      6 Haynes RB, "Interventions for enhancing medication adherence" 16 : 2008

      7 Nanes MS, "Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis" 92 : 403-412, 2009

      8 Coope J, "Can We Improve Compliance with Long-Term Hrt" 15 : 151-158, 1992

      9 Claxton AJ, "A systematic review of the associations between dose regimens and medication compliance" 23 : 1296-1310, 2001

      10 Dawson-Hughes B, "A revised clinician's guide to the prevention and treatment of osteoporosis" 93 : 2463-2465, 2008

      1 Hamilton B, "Tolerability and compliance with risedronate in clinical practice" 14 : 259-262, 2003

      2 Rees MCP, "The need to improve compliance to HRT" 104 : 1-3, 1997

      3 Park HM, "The Use of Osteoporosis Medications in Korea in 2008" 16 : 87-93, 2009

      4 Chung JY, "Practice Patterns on Osteoporosis Screening and Treatment at Orthopaedic Surgery Outpatient Unit and the Issue on Different Osteoporosis Treatment Guidelines in Korea" 15 : 49-57, 2008

      5 Imaz I, "Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis" 21 : 1943-1951, 2010

      6 Haynes RB, "Interventions for enhancing medication adherence" 16 : 2008

      7 Nanes MS, "Clinical assessment of fracture risk and novel therapeutic strategies to combat osteoporosis" 92 : 403-412, 2009

      8 Coope J, "Can We Improve Compliance with Long-Term Hrt" 15 : 151-158, 1992

      9 Claxton AJ, "A systematic review of the associations between dose regimens and medication compliance" 23 : 1296-1310, 2001

      10 Dawson-Hughes B, "A revised clinician's guide to the prevention and treatment of osteoporosis" 93 : 2463-2465, 2008

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2016-05-01 평가 학술지 통합(기타)
      2015-01-01 평가 등재후보학술지 유지(등재후보1차) KCI등재후보
      2013-01-01 평가 등재후보학술지 유지(기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지(기타) KCI등재후보
      2011-05-24 학술지명변경 한글명 : OSTEOPOROSIS</br>외국어명 : The Journal of Korean Society of Osteoporosis KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS(등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보학술지 선정(신규평가) KCI등재후보
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼